Prestige Consumer Healthcare Announces Executive and Board Changes
Ticker: PBH · Form: 8-K · Filed: May 8, 2024 · CIK: 1295947
| Field | Detail |
|---|---|
| Company | Prestige Consumer Healthcare Inc. (PBH) |
| Form Type | 8-K |
| Filed Date | May 8, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-composition
TL;DR
Prestige Consumer Healthcare shakes up C-suite and board with new CFO and directors.
AI Summary
Prestige Consumer Healthcare Inc. announced on May 8, 2024, changes in its executive team and board of directors. The company elected two new directors, Dr. David R. Johnson and Ms. Jennifer L. Smith, to its Board, effective immediately. Additionally, the company announced the appointment of Ms. Sarah M. Mook as its new Chief Financial Officer, succeeding Mr. Steven J. Gremban, who will transition to a senior advisor role.
Why It Matters
These changes in leadership and board composition could signal a strategic shift or a response to recent performance, impacting the company's future direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key executive positions and board composition can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Prestige Consumer Healthcare Inc. (company) — Registrant
- Dr. David R. Johnson (person) — Newly elected director
- Ms. Jennifer L. Smith (person) — Newly elected director
- Ms. Sarah M. Mook (person) — Newly appointed Chief Financial Officer
- Mr. Steven J. Gremban (person) — Outgoing Chief Financial Officer
FAQ
Who were the new directors elected to the Board of Directors?
Dr. David R. Johnson and Ms. Jennifer L. Smith were elected as new directors.
When were the board and executive changes effective?
The changes were reported as of May 8, 2024.
Who is the new Chief Financial Officer?
Ms. Sarah M. Mook has been appointed as the new Chief Financial Officer.
What will be the role of the outgoing CFO, Mr. Steven J. Gremban?
Mr. Steven J. Gremban will transition to a senior advisor role.
What is the principal executive office address for Prestige Consumer Healthcare Inc.?
The principal executive offices are located at 660 White Plains Road, Tarrytown, New York 10591.
Filing Stats: 620 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-05-08 17:08:14
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share PBH New York Stock Exchange
Filing Documents
- tm2413945d1_8k.htm (8-K) — 23KB
- 0001104659-24-058841.txt ( ) — 190KB
- pbh-20240508.xsd (EX-101.SCH) — 3KB
- pbh-20240508_lab.xml (EX-101.LAB) — 33KB
- pbh-20240508_pre.xml (EX-101.PRE) — 22KB
- tm2413945d1_8k_htm.xml (XML) — 3KB
02 Departure of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The Company today announced that John F. Kelly, former Vice President Quality Operations and Environment, Health & Safety at Pfizer Inc. was elected to the Company's Board of Directors on May 7, 2024. Mr. Kelly was appointed to the Company's Compensation and Talent Management and Nominating and Corporate Governance Committees. John F. Kelly retired in 2022 from a 40-year career with Pfizer Inc, a biopharmaceutical company. He was a member of the Pfizer Global Supply Leadership Team and a member of the Pfizer PAC Board of Directors. Mr. Kelly was Vice President, Quality Operations and Environment, Health & Safety (EHS), responsible for leading the overall Quality function for Pfizer Inc and global EHS across the Company. Mr. Kelly was previously responsible for pharmaceutical and consumer product operations, manufacturing strategy, manufacturing business development, quality and EHS. He was also Chairman of the Board of Directors of Zydus Cadila Oncology Private Limited, a 50/50 joint venture between Pfizer and Zydus Cadila. Mr. Kelly is also Chairman of the Board of Trustees of Wakeman Boys & Girls Club, and a member of the Worcester Polytechnic Institute Engineering Dean's Advisory Board. Mr. Kelly earned a degree in Chemical Engineering from Worcester Polytechnic Institute and an MBA in Operations Management from Pace University. Mr. Kelly was not selected pursuant to any arrangement or understanding between him and any other person. There have been no related person transactions between the Company and Mr. Kelly reportable under Item 404(a) of Regulation S-K.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 8, 2024 PRESTIGE CONSUMER HEALTHCARE INC. By: /s/ Christine Sacco Christine Sacco Chief Financial Officer